ST Pharm
ST Pharm
  • 01Who we are
  • 02Our record
  • 03Newsroom
  • 04Contact
    • En
    • Ko
ST Pharm
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
    • CI
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
Public
ST PHARM News
  • PR (Public Relations)
    • News room
      • All
      • Media Focus
      • ST PHARM News
  • IR (Investor Relations)
    • Stock Information
    • IR Library
      • Disclosure Information
      • IR Materials
      • Notice

ST PHARM's Public Release

  • All
  • Media Focus
  • ST PHARM News
ST PHARM NewsST Pharm, honored with two awards at the ‘Korea Biopharma Excellence Awards 2024’Aug 19, 2024
ST PHARM NewsST PHARM's Participation in 2024 DCAT Week Highlights Innovation in Pharmaceutical SectorMar 20, 2024
ST PHARM News[Notice] RNA Innovation Symposium Corea/Korea 2024 (RISC 2024)Feb 26, 2024
ST PHARM NewsST PHARM, Pirmitegravir (STP0404), HIV: Three trials to watch in 2024Jan 15, 2024
ST PHARM News[ST Pharm Webinar Series] mRNA TechnologiesDec 14, 2023
ST PHARM News[Tides Europe 2023] Exploring Excellence in Oligonucleotide CDMO services at ST PharmDec 14, 2023
ST PHARM News'100-Day Expedite Strategy', Preparedness and Proactive Measures for Future PandemicNov 21, 2023
ST PHARM News'To Become a Global Korean CDMO' - 2023 Economic Daily Pharmaceutical Bio ForumNov 21, 2023
ST PHARM NewsInvesting in mRNA platforms to create CDMO-biotech partnership opportunitiesNov 13, 2023
ST PHARM NewsVisit of the International Vaccine Institute (IVI) Board of Trustees at ST PharmNov 9, 2023
ST PHARM News[ST Pharm Leaflet] Small MoleculeOct 31, 2023
ST PHARM News[ST Pharm Leaflet] Generic APIOct 31, 2023
ST PHARM News[ST Pharm Leaflet] MonomerOct 31, 2023
2of4
HOMEPublicPR (Public Relations)News roomST PHARM News
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
    • CI
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
© 2025 ST Pharm. All rights reserved.
  • Sitemap
  • Contact